IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
24 hedge funds and large institutions have $8.68M invested in Interpace Biosciences, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$268K | |
| 2 | +$126K | |
| 3 | +$9.16K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.89K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$654 |
Top Sellers
| 1 | -$254K | |
| 2 | -$117K | |
| 3 | -$51K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$48.4K |
| 5 |
PHS
Pekin Hardy Strauss
Chicago,
Illinois
|
-$32.2K |